Asking Who Is to Blame for an Overdose Is the Wrong Question. Asking What Would Have Stopped It Is Not

Asking Who Is to Blame for an Overdose Is the Wrong Question. Asking What Would Have Stopped It Is Not

Two celebrity overdose deaths have put a familiar argument back in circulation: that looking for someone to blame is a mistake, because addiction has no single cause. The argument is correct as far as it goes. The difficulty is where it stops.

A Yahoo News feature published on 1 October set out the case, drawing on Nora Volkow of the National Institute on Drug Abuse, bereaved families, and the writer Nadia Bowers, whose sister died of a fentanyl overdose in 2015. The deaths of the actor Hayden Panettiere and the model Presley Gerber, both reported as suspected overdoses, had drawn a wave of online accusation aimed at parents, partners, industries and the people themselves.

The piece is right that this impulse helps nobody. What it does not do is separate blame from prevention, and they are not the same thing.

What the experts actually said

Volkow’s point is about causes, not absolution. “Who do you blame?” she asked. “The person that’s taking the drug? Do you blame the dealer that sold them that drug? Do you blame the health care system that didn’t screen or provide the support for that person? Do you blame the family that didn’t pay attention?”

Read as a list of failures rather than a list of suspects, that is a prevention agenda. A health system that does not screen is a fixable thing. A system that pays doctors less for treating addiction than for treating other diseases, which Volkow identifies as a live problem, is a fixable thing. A supply chain delivering fentanyl to a 44 year old woman is a fixable thing.

Bowers, who spent years writing letters to the dealer she held responsible, reaches a similar place from the other direction. “The fact that these drugs are so available, that’s a systems problem,” she said, “and the fact that there’s a demand is a human problem: People are in pain.”

Availability and demand. Those are the two levers prevention works on, and both appear in the article as asides.

The point where the argument slips

Blame looks backwards and asks who deserves punishment. Prevention looks forwards and asks what would have interrupted the sequence earlier. Only the first is useless to a grieving family.

The slippage happens when the case against blame becomes a case against accountability of any kind. If no one is responsible for a death, no one is responsible for preventing the next one either. The commercial actors who profit from a market in addictive products have every reason to encourage that conclusion, and little reason to distinguish between moral blame and structural responsibility.

Justin Phillips of Overdose Lifeline described the guilt behind the finger-pointing after Panettiere’s death: “She was suffering, and maybe that is part of our guilt and why we are looking for someone to blame: No one stepped up and tried to help.”

Nobody stepping up is not a mystery of human nature. It is a gap, and gaps can be closed.

What the piece credits for the decline

Overdose deaths in the United States have fallen from a peak above 107,000 in 2022 to roughly 70,000 in 2025. The article attributes the fall to three things: wider naloxone availability, changes in the drug supply, and an increase in harm reduction efforts.

Demand reduction does not appear on that list. Neither does prevention. Two of the three credited factors are responses to an overdose already in progress, and the third is a change in what the illicit market happened to be selling.

Seventy thousand deaths a year is not a solved problem, and Bowers says as much: “It’s far from over.” A strategy built almost entirely on catching people at the point of collapse will keep producing numbers like that one. Stopping the first use, and intervening early when use begins, is the part of the work that has been left thin.

Where stigma and prevention are confused

The article’s strongest material is on isolation. Brendan Little of Halo Initiatives made the point that admitting a relapse is hard for anyone and close to impossible under public scrutiny: “If you’re a public figure who’s under a microscope like these guys were, how does that fit in the PR package?” Isolation is a serious risk factor, and shame drives it.

He also described what happens to families afterwards. One father told him he “had all of these people coming to me when my son was struggling”, and after the son’s death, “it was just like crickets.”

None of that is in tension with prevention. Telling young people plainly that these products are dangerous is not the same as telling a bereaved mother she failed. The two get conflated constantly, and the conflation has a cost: fear of sounding judgmental has made clear prevention messaging harder to deliver than it should be.

The question worth keeping

Volkow’s analogy is the one to hold onto. “If you get a diagnosis of cancer, you don’t stop and say, ‘Maybe we treat it, maybe not.’ You actually intervene with the most powerful tools we have, but that’s not how we conceptualise addiction.”

Cancer care does not stop at treatment either. It runs on screening, on early detection, and on reducing exposure to the things that cause it in the first place. That is the comparison taken seriously.

So drop the blame. Keep the question underneath it. For every one of those 70,000 deaths there was a point at which something different could have happened, and identifying those points is not an accusation against anyone. It is the only part of this that changes next year’s number.

Source: Yahoo

Leave a Reply

Your email address will not be published.